Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease.
Open Access
- 1 May 1984
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 47 (5) , 485-491
- https://doi.org/10.1136/jnnp.47.5.485
Abstract
Subcutaneous or intravenous administration of physostigmine improved the copying of geometric figures in three out of six patients with presumed Alzheimer's disease who showed a remarkable constructional disturbance. This improvement reached its maximum 30 to 60 minutes after the physostigmine administration. These results not only provide further evidence supporting the hypothesis that central cholinergic potentiation ameliorates some of the impairments of Alzheimer's disease, but implicate a possible important role of the cholinergic system in the integration of constructional praxis.This publication has 15 references indexed in Scilit:
- Memory Enhancement with Oral Physostigmine in Alzheimer's DiseaseNew England Journal of Medicine, 1983
- Intrusions as a sign of Alzheimer dementia chemical and pathological verificationAnnals of Neurology, 1982
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Effects of physostigmine and lecithin on memory in Alzheimer diseaseAnnals of Neurology, 1979
- Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's DiseaseArchives of Neurology, 1979
- PHYSOSTIGMINE IN ALZHEIMER'S DISEASEThe Lancet, 1979
- Memory Enhancement After Physostigmine Treatment in the Amnesic SyndromeArchives of Neurology, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976
- Cerebral Blood Flow in DementiaArchives of Neurology, 1975